Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05663164Completed
Randomised, triple-blind trial of thiamine in sepsis, sponsored by Universitas Sumatera Utara. Primary endpoints: Glucagon at 72 hours and Reactive Oxygen Species at 72 hours. Started Oct 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05663164.